leucokinin I: an eight amino acid neuropeptide found in the nervous system of the bowfly; aa sequence given in first source [MeSH]
Leucokinin I : no description available [CHeBI]
ID Source | ID |
---|---|
PubMed CID | 5491285 |
CHEBI ID | 80183 |
MeSH ID | M0223146 |
Synonym |
---|
leucokinin i |
104600-89-7 |
(3s)-3-amino-4-[(2s)-2-[[(2s)-1-[[(2s)-1-[[(2s)-4-amino-1-[[(2s)-1-[[(2s)-1-[(2-amino-2-oxoethyl)amino]-3-(1h-indol-3-yl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-y |
asp-pro-ala-phe-asn-ser-trp-gly-nh2 |
leukokinin i |
CHEBI:80183 |
DTXSID90146608 |
J-001201 |
glycinamide, l-alpha-aspartyl-l-prolyl-l-alanyl-l-phenylalanyl-l-asparaginyl-l-seryl-l-tryptophyl- |
Q27149296 |
(s)-4-((s)-2-(((5s,8s,11s,14s,17s)-5-((1h-indol-3-yl)methyl)-1-amino-11-(2-amino-2-oxoethyl)-14-benzyl-8-(hydroxymethyl)-1,4,7,10,13,16-hexaoxo-3,6,9,12,15-pentaazaoctadecan-17-yl)carbamoyl)pyrrolidin-1-yl)-3-amino-4-oxobutanoic acid |
glycinamide,l-alpha-aspartyl-l-prolyl-l-alanyl-l-phenylalanyl-l-asparaginyl-l-seryl-l-tryptophyl- |
AKOS040744659 |
Class | Description |
---|---|
peptide | Amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another with formal loss of water. The term is usually applied to structures formed from alpha-amino acids, but it includes those derived from any amino carboxylic acid. X = OH, OR, NH2, NHR, etc. |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (76.92) | 18.2507 |
2000's | 3 (23.08) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 14 (100.00%) | 84.16% |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
potassium chloride | inorganic chloride; inorganic potassium salt; potassium salt | fertilizer | 2008 | 2008 | 16.0 | medium | 0 | 0 | 0 | 1 | 0 | 0 | |
substance p | peptide | neurokinin-1 receptor agonist; neurotransmitter; vasodilator agent | 1994 | 1994 | 30.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | |
arginylphenylalaninamide | 1995 | 1995 | 29.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | |||
locustakinin | 1995 | 1995 | 29.0 | high | 0 | 0 | 1 | 0 | 0 | 0 | |||
locustatachykinin ii protein, locusta migratoria | 1995 | 1995 | 29.0 | high | 0 | 0 | 1 | 0 | 0 | 0 | |||
lypressin | cyclic peptide | 1995 | 1995 | 29.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | ||
allatostatin 1 | 1995 | 1995 | 29.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | |||
perisulfakinin | 1995 | 1995 | 29.0 | high | 0 | 0 | 1 | 0 | 0 | 0 | |||
corazonin protein, insect | 1995 | 1995 | 29.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | |||
allatotropin | 1995 | 1995 | 29.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 |
Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Muscle Contraction | 0 | 2006 | 2006 | 18.0 | high | 0 | 0 | 0 | 1 | 0 | 0 |